Clinical Mass Spectrometry Market by End-User (Healthcare Facilities and Pharma and Biotech Companies and Research Labs and Institutes) and Geography (Asia, Europe, North America, and ROW) | COVID-19 Impact Analysis

LONDON–()–Technavio has been monitoring the clinical mass spectrometry market and it is poised to grow by USD 1.70 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44340

This Report Addresses:

  • The market size from 2020-2024
  • Expected market growth until 2024
  • Forecast of how market drivers, restraints, and future opportunities will affect the market dynamics
  • Segments and regions that will drive or lead market growth and why
  • Comprehensive mapping of the competitive landscape
  • In-depth analysis of key sustainability strategies adopted by market players

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions-

  • Based on segmentation by end-user, which is the leading segment in the market?
  • Healthcare facilities and pharma and biotech companies are expected to be the leading segment based on end-user in the global market during the forecast period.
  • What are the major trends in the market?
  • Increasing demand for clinical mass spectrometry in personalized medicine is one of the major trends in the market.
  • At what rate is the market projected to grow?
  • Growing at a CAGR of almost 6%, the incremental growth of the market is anticipated to be USD 1.70 billion.
  • Who are the top players in the market?
  • Agilent Technologies Inc., Bruker Corp., Danaher Corp., Hitachi Ltd., JEOL Ltd., Kore Technology Ltd., PerkinElmer Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp. are some of the major market participants.
  • What are the key market drivers and challenges?
  • Rise in geriactric population is one of the major factors driving the market. However, the high cost of instruments will restrain market growth.
  • How big is the Europe market?
  • The Europe region will contribute 30% of market growth.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Agilent Technologies Inc., Bruker Corp., Danaher Corp., Hitachi Ltd., JEOL Ltd., Kore Technology Ltd., PerkinElmer Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp. are some of the major market participants. The rise in geriactric population will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Clinical Mass Spectrometry Market 2020-2024: Segmentation

Clinical Mass Spectrometry Market is segmented as below:

  • End-user

    • Healthcare Facilities and Pharma and Biotech Companies
    • Research Labs and Institutes
  • Geography

    • North America
    • Europe
    • Asia
    • ROW

Clinical Mass Spectrometry Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The clinical mass spectrometry market report covers the following areas:

  • Clinical Mass Spectrometry Market Size
  • Clinical Mass Spectrometry Market Trends
  • Clinical Mass Spectrometry Market Analysis

This study identifies increasing demand for clinical mass spectrometry in personalized medicine as one of the prime reasons driving the clinical mass spectrometry market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Clinical Mass Spectrometry Market 2020-2024: Key Highlights

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will assist clinical mass spectrometry market growth during the next five years
  • Estimation of the clinical mass spectrometry market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the clinical mass spectrometry market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of clinical mass spectrometry market vendors

Table of Contents:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Healthcare facilities and pharma and biotech companies – Market size and forecast 2019-2024
  • Research labs and institutes – Market size and forecast 2019-2024
  • Market opportunity by End-user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Bruker Corp.
  • Danaher Corp.
  • Hitachi Ltd.
  • JEOL Ltd.
  • Kore Technology Ltd.
  • PerkinElmer Inc.
  • Shimadzu Corp.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations 

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Source

About the Author: Biotech Today

You might like